Skip to main content
      A prediction model for RA-ILD in RA pts: is it possible?

      Not quite yet!

      Veterans Affairs RA registry 2700+ pts

      5% of

      Aurelie Najm AurelieRheumo

      4 months 1 week ago
      A prediction model for RA-ILD in RA pts: is it possible? Not quite yet! Veterans Affairs RA registry 2700+ pts 5% of prevalent ILD Associated w/ -GDF-15 -Pentraxin 3 No prediction for Incident disease Needs more work to understand implications for practice @RheumNow #ACR25 https://t.co/CmW72nybcQ
      Does specific ANCA subtype inform infectious risk?

      Retrospective review of 270 AAV patients revealed that about 1/3 pt

      Brian Jaros, MD Dr_Brian_MD

      4 months 1 week ago
      Does specific ANCA subtype inform infectious risk? Retrospective review of 270 AAV patients revealed that about 1/3 pt developed severe infections... of these: - 64.1% MPO+ - 35.9% PR3+ Most infx during year 1 of tx No difference between CYC vs. RTX @RheumNow #ACR25 abst 2510
      Gender differences in p/axSpA in Turkiye from ASAS-PerSpA:

      Males - early onset IBP (<45yrs); sacroiliitis on CR, HL

      sheila RHEUMarampa

      4 months 1 week ago
      Gender differences in p/axSpA in Turkiye from ASAS-PerSpA: Males - early onset IBP (<45yrs); sacroiliitis on CR, HLA-B27+ (vs. females) Females - peripheral dse, enthesitis, Pso, dactylitis; ⬆️dse activity, FM (vs. males) Individualize & optimize tx. #ACR25 @RheumNow Abs2322 https://t.co/vcisNguJLB
      Great debate on GCA ultrasound vs biopsy. Wolfgang Schmidt making the case for GCA US with the rise of its use in guidel

      Antoni Chan MD (Prof) synovialjoints

      4 months 1 week ago
      Great debate on GCA ultrasound vs biopsy. Wolfgang Schmidt making the case for GCA US with the rise of its use in guidelines @RheumNow #ACR25 https://t.co/ORxzzG8xnF
      Simulation modeling by Patel et al helps generate probability of remission, relapse, and adverse events in newly dx AAV

      Brian Jaros, MD Dr_Brian_MD

      4 months 1 week ago
      Simulation modeling by Patel et al helps generate probability of remission, relapse, and adverse events in newly dx AAV Projected risk by model were similar to observed rates in RCTs @RheumNow #ACR25 Abst 1764 https://t.co/xevkJ2Ih0M
      Rotation or Change in Biologic post TNFi failure in axSpA. Switching biologic class after TNFi failure improved outcomes

      Antoni Chan MD (Prof) synovialjoints

      4 months 1 week ago
      Rotation or Change in Biologic post TNFi failure in axSpA. Switching biologic class after TNFi failure improved outcomes in axial SpA. In a randomized trial of axSpA patients with inadequate response to a first TNFi, switching to an IL-17Ai was not superior to cycling to a second https://t.co/MEsokWeT8e
      This cohort study from Ontario of 🚺w/axSpA
      ✳️GDM, antepartum hem, SMM (severe maternal morbidity) -⬆️ in axSp

      sheila RHEUMarampa

      4 months 1 week ago
      This cohort study from Ontario of 🚺w/axSpA ✳️GDM, antepartum hem, SMM (severe maternal morbidity) -⬆️ in axSpA ✳️Neonat complications-preterm birth Factors assoc w/SMM- age, comorbidity, gestational age at delivery Better strategies for maternal care #ACR25 @RheumNow Abs2200 https://t.co/LrVzJLnvWe
      HCQ weight-based dosing: out
      HCQ whole blood monitoring: in

      Whole blood levels more precisely balance risks of SLE flar

      Brian Jaros, MD Dr_Brian_MD

      4 months 1 week ago
      HCQ weight-based dosing: out HCQ whole blood monitoring: in Whole blood levels more precisely balance risks of SLE flare (under-dosing) vs. toxicitiy (over-dosing) Many pt on <5 mg/kg had supra-therapeutic blood levels with risk for toxicity @RheumNow #ACR25 #ACRBest Abst 1722 https://t.co/qIbACxAW39
      Screen RA ILD Properly
      Perspectives on CAR T Therapy
      Mimics of ANCA-associated vasculitis: How can we tell?

      With increased disease awareness and more regular, accessible te

      Dr. John Cush RheumNow

      4 months 1 week ago
      Mimics of ANCA-associated vasculitis: How can we tell? With increased disease awareness and more regular, accessible testing for anti-neutrophil cytoplasmic antibodies (ANCA), ANCA-associated vasculitis (AAV) has become an increasingly recognized clinical entity in rheumatologic https://t.co/LYRk0rHlzx
      The ACR Convergence 2025 in Chicago opens with engaging topics curated for the global rheumatologist. As a clinician, I always look forward to sessions that provide updates and practical key points that I can bring home and apply to my practice.
      ×